Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers.

Autor: Castelo L; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil; Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil. Electronic address: fcastelo.lucas@gmail.com., da Silva WF; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil., Lincango M; Laboratorio de Genética Hematológica, Instituto de Medicina Experimental (IMEX-CONICET)/ Academia Nacional de Medicina, Buenos Aires, Argentina., Buccheri V; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil., Perusini A; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Arbelbide J; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina., Gonzalez J; Hospital General de Agudos Carlos Durand, Buenos Aires, Argentina., Pereyra P; Hospital Nacional Alejandro Posadas, El Palomar, Provincia de Buenos Aires, Argentina., Pereira TDM; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil., Marchi LL; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil., Rocha V; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil., Belli CB; Laboratorio de Genética Hematológica, Instituto de Medicina Experimental (IMEX-CONICET)/ Academia Nacional de Medicina, Buenos Aires, Argentina., Velloso EDRP; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil; Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil.
Jazyk: angličtina
Zdroj: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Jun; Vol. 24 (6), pp. 407-411. Date of Electronic Publication: 2024 Feb 14.
DOI: 10.1016/j.clml.2024.02.003
Abstrakt: Competing Interests: Disclosures The authors have no competing interest to declare that are relevant to the content of this article.
Databáze: MEDLINE